Cardinal Health entered into a new $4.0 billion unsecured revolving credit facility on August 7, 2026, replacing its existing Five-Year Credit Agreement ($2.0 billion), 364-Day Credit Agreement ($1.0 billion), and Receivables Purchase Agreement ($1.0 billion). The new facility terminates on August 7, 2031, with an option to extend for up to two years, and requires a Consolidated Net Leverage Ratio of no greater than 4.00 to 1.00. No penalties were incurred upon termination of the prior facilities. Cardinal Health operates in the healthcare supply chain industry, providing medical products and services.
